Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
$1.62
-0.9%
$1.07
$0.65
$26.25
$17.01M1.23777,080 shs91,572 shs
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$35.42
+1.9%
$1.90
$33.92
$37.24
$25.89M0.161,370 shs2,893 shs
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
$0.12
-0.3%
$0.13
$0.10
$0.25
$38.70M132,194 shs8,000 shs
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.67
-2.3%
$1.74
$0.95
$11.92
$195.51M1.181.19 million shs1,600 shs
Teligent, Inc. stock logo
TLGT
Teligent
$0.03
$0.17
$1.60
N/AN/AN/A6,460 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
-7.91%-25.74%+53.77%+73.40%-91.26%
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
+0.21%-0.21%+1.09%+2.98%-0.51%
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-0.34%+8.27%-3.60%-6.58%-43.90%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-3.39%-6.30%-18.96%-31.33%-80.02%
Teligent, Inc. stock logo
TLGT
Teligent
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
2.4932 of 5 stars
3.42.00.00.02.00.81.3
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.1608 of 5 stars
0.03.00.00.00.00.00.6
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
2.80
Moderate Buy$53.003,181.73% Upside
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
0.00
N/AN/AN/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
0.00
N/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.00
N/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SXTC, SEOVF, EYEG, TLGT, and CTXR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00
6/9/2025
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00
5/23/2025
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/23/2025
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/15/2025
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
N/AN/AN/AN/A$10.25 per shareN/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$10K2,656.13N/AN/A$1.26 per share28.11
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/A($0.03) per shareN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.93M100.40N/AN/A$243.66 per share0.01
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
-$39.14MN/A0.001.29N/AN/A-58.63%-37.67%8/11/2025 (Estimated)
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
-$8.09M-$1.68N/AN/AN/AN/A-104.96%-60.03%N/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
-$23.65M-$0.04N/AN/AN/AN/A-396.49%9/15/2025 (Estimated)
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-$3.10MN/A0.00N/AN/AN/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest SXTC, SEOVF, EYEG, TLGT, and CTXR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/13/2025Q2 2025
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A-$0.01N/A-$0.01N/AN/A
5/14/2025Q2 2025
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
-$1.08-$1.27-$0.19-$1.27N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
N/AN/AN/AN/AN/A
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$2.105.93%N/AN/A N/A
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/AN/AN/A

Latest SXTC, SEOVF, EYEG, TLGT, and CTXR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/30/2025
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.14234.81%7/1/20257/1/20257/7/2025
5/30/2025
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
Monthly$0.15075.19%6/2/20256/2/20256/5/2025
4/30/2025
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
$0.15015/1/20255/1/20255/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
N/A
0.37
0.06
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
0.01
3.07
3.07
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A
0.12
0.12
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/A
Teligent, Inc. stock logo
TLGT
Teligent
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
2010.63 million9.50 millionOptionable
AB Corporate Bond ETF stock logo
EYEG
AB Corporate Bond ETF
14750,0005.28 millionNot Optionable
Sernova Biotherapeutics Inc. stock logo
SEOVF
Sernova Biotherapeutics
N/A328.48 millionN/ANot Optionable
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
90116.03 million111.45 millionNot Optionable
Teligent, Inc. stock logo
TLGT
Teligent
2,357N/AN/AOptionable

Recent News About These Companies

PAC Profile: Teligent
IDT Corp. Cl B

New MarketBeat Followers Over Time

Media Sentiment Over Time

Citius Pharmaceuticals stock logo

Citius Pharmaceuticals NASDAQ:CTXR

$1.62 -0.02 (-0.92%)
As of 10:32 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives products in adjunct cancer care, prescription products, and stem cell therapy. It is developing five proprietary products comprising LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma, which is in Phase 3 clinical trial; Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase 3 clinical trial; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids that is in clinical Phase 2b trial; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. The company was founded in 2007 and is headquartered in Cranford, New Jersey.

AB Corporate Bond ETF stock logo

AB Corporate Bond ETF NASDAQ:EYEG

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Sernova Biotherapeutics stock logo

Sernova Biotherapeutics OTCMKTS:SEOVF

$0.12 0.00 (-0.34%)
As of 10:07 AM Eastern

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

China SXT Pharmaceuticals stock logo

China SXT Pharmaceuticals NASDAQ:SXTC

$1.67 -0.04 (-2.34%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Teligent stock logo

Teligent NASDAQ:TLGT

Teligent, Inc. engages in the development, manufacture, and market of topical and branded generic and generic injectable pharmaceutical products. It also provides contract manufacturing services to the pharmaceutical, over-the-counter, and cosmetic markets. The company was founded by Jane E. Hager in 1977 and is headquartered in Buena, NJ.